Variant report
Variant | nsv1053832 |
---|---|
Chromosome Location | chr10:56022197-56061600 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547735360 | chr10:56041605-56041606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148888732 | chr10:56041608-56041609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531999647 | chr10:56041616-56041617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146980825 | chr10:56041618-56041619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7918002 | chr10:56041626-56041627 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs549887867 | chr10:56041646-56041647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138225533 | chr10:56041684-56041685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569907589 | chr10:56041685-56041686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535643832 | chr10:56041737-56041738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555046804 | chr10:56041782-56041783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181959555 | chr10:56041798-56041799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565924387 | chr10:56041836-56041837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562434286 | chr10:56041862-56041863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112933364 | chr10:56041881-56041882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115174705 | chr10:56041896-56041897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs61853312 | chr10:56041906-56041907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372190470 | chr10:56041939-56041940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577897529 | chr10:56041951-56041952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543627375 | chr10:56041982-56041983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529642451 | chr10:56041986-56041987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547822717 | chr10:56042026-56042027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185823469 | chr10:56042051-56042052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7907468 | chr10:56042069-56042070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76576828 | chr10:56042111-56042112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189602075 | chr10:56042128-56042129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12262364 | chr10:56042135-56042136 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs527679465 | chr10:56042202-56042203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547795507 | chr10:56042205-56042206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35804115 | chr10:56042236-56042237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574462397 | chr10:56042247-56042248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181203449 | chr10:56042278-56042279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564606939 | chr10:56042325-56042326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527393504 | chr10:56042367-56042368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186758460 | chr10:56042388-56042389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188090431 | chr10:56043604-56043605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374228100 | chr10:56043611-56043612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376739976 | chr10:56043615-56043616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370895250 | chr10:56043619-56043620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10825296 | chr10:56043660-56043661 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs541378075 | chr10:56043685-56043686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143837572 | chr10:56043700-56043701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528682277 | chr10:56043733-56043734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551417447 | chr10:56043745-56043746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532372519 | chr10:56043759-56043760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571408891 | chr10:56043762-56043763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530519941 | chr10:56043769-56043770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11593951 | chr10:56043784-56043785 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs567283906 | chr10:56043810-56043811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536521121 | chr10:56043826-56043827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546579290 | chr10:56043840-56043841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56041600-56042200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr10:56041600-56042200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr10:56041600-56042200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr10:56041800-56042200 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr10:56041800-56042400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr10:56043600-56044000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr10:56048600-56048800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr10:56058800-56066400 | Weak transcription | H9 Cell Line | embryonic stem cell |